NTRK Fusions: Whom to Test? When to Test?

Download these slides to review how and when to test for NTRK fusions in patients with head and neck cancer.
Aarti Bhatia, MD, MPH
Format: Microsoft PowerPoint (.ppt)
File Size: 399 KB
Released: January 5, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bayer HealthCare Pharmaceuticals Inc.
Merck Sharp & Dohme Corp.

Related Content

Domenica Lorusso, MD, PhD, on the molecular reclassification of endometrial cancers and key ongoing immunotherapy trials, from Clinical Care Options (CCO)

Domenica Lorusso, MD, PhD Released: February 25, 2021

Get expert insights from Clinical Care Options (CCO) on how to talk to your patients with lung or thyroid cancer about precision medicine

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP Released: February 23, 2021

Gain key clinical insights quickly with this short slideset from Clinical Care Options (CCO) on the integration of CAR T-cell therapy for leukemias, lymphomas, and myeloma

Renier J. Brentjens, MD, PhD Frederick L. Locke, MD Noopur Raje, MD Released: February 18, 2021

On-demand Webcast from Clinical Care Options (CCO) on latest data on the use of RET inhibitors for patients with RET-altered NSCLC and thyroid cancer

Taofeek K. Owonikoko, MD, PhD Physicians: maximum of 0.75 AMA PRA Category 1 Credits ABIM MOC: maximum of 0.75 Medical Knowledge MOC point(s) ABPath MOC: maximum of 0.75 Lifelong Learning (Part II) and Self-Assessment Module (SAM) point(s) Released: February 12, 2021 Expired: February 11, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue